Regulon

Regulon: R-2866

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
150.92710510Pr-95Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1634 ENSG00000011465 DCN F8VU58
3459 ENSG00000027697 IFNGR1 A0A2R8Y4U4
2280 ENSG00000088832 FKBP1A P62942
8773 ENSG00000092531 SNAP23 H3BNG6
1390 ENSG00000095794 CREM E9PAR2
2217 ENSG00000104870 FCGRT P55899
969 ENSG00000110848 CD69 Q07108
4033 ENSG00000118308 LRMP F5H006
3762 ENSG00000120457 KCNJ5 P48544
58533 ENSG00000129515 SNX6 A0A0A0MRI2
474344 ENSG00000133561 GIMAP6 B4DH95
53346 ENSG00000136404 TM6SF1 Q9BZW5
54491 ENSG00000145569 FAM105A Q9NUU6
7941 ENSG00000146070 PLA2G7 Q13093
10924 ENSG00000172594 SMPDL3A Q92484

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RILAPLADIBPLA2G7Small moleculeINHIBITORLDL-associated phospholipase A2 inhibitor20
TACROLIMUSFKBP1ASmall moleculeINHIBITORFK506-binding protein 1A inhibitor40
INTERFERON GAMMA-1BIFNGR1ProteinAGONISTInterferon gamma receptor agonist40
TEMSIROLIMUSFKBP1ASmall moleculeINHIBITORFK506-binding protein 1A inhibitor42
BATOCLIMABFCGRTAntibodyINHIBITORIgG receptor FcRn large subunit p51 inhibitor20
NIPOCALIMABFCGRTAntibodyANTAGONISTIgG receptor FcRn large subunit p51 antagonist30
EVEROLIMUSFKBP1ASmall moleculeINHIBITORFK506-binding protein 1A inhibitor44
DARAPLADIBPLA2G7Small moleculeINHIBITORLDL-associated phospholipase A2 inhibitor30
SIROLIMUSFKBP1ASmall moleculeINHIBITORFK506-binding protein 1A inhibitor41
EFGARTIGIMOD ALFAFCGRTProteinANTAGONISTIgG receptor FcRn large subunit p51 antagonist30
ROZANOLIXIZUMABFCGRTAntibodyINHIBITORIgG receptor FcRn large subunit p51 inhibitor30
VERNAKALANTKCNJ5Small moleculeBLOCKERKir3.1/Kir3.4 blocker40
VERNAKALANT HYDROCHLORIDEKCNJ5Small moleculeBLOCKERKir3.1/Kir3.4 blocker30
PIMECROLIMUSFKBP1ASmall moleculeINHIBITORFK506-binding protein 1A inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2866

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs